QNRX logo

Quoin Pharmaceuticals, Ltd.

QNRX
Healthcare|Biotechnology|US
$3.65
-0.20 (-5.19%)
DCF Value
$2547.50
Tangible Book / Share
$5.63
Cash / Share
$2.00
Next Earnings Report
Mar 25, 2027
EPS est. -$1.36
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Nov 4, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (3)

Dec 2026
Est. completion
P2P3Netherton Syndrome
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT06953466n=8
Dec 2026
Est. completion
P2P3Netherton Syndrome
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05789056n=20
Jan 2027
Est. completion
P2P3Netherton Syndrome
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT07538583n=16

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Dec 2025
P2P3
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05521438

Recent Press Releases

Quoin Pharmaceuticals' Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome
Nov 6, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Nov 5, 2026 · GlobeNewsWire
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Oct 29, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
Oct 20, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Oct 14, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
Oct 6, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Sep 22, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah's Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
Sep 10, 2026 · GlobeNewsWire
CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Sep 8, 2026 · GlobeNewsWire
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Sep 8, 2026 · GlobeNewsWire

SEC Filings (104)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20268-KMaterial eventDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 4, 2026EFFECTDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Nov 4, 2026424B5Offering prospectusDocumentIndex
Nov 4, 2026424B5Offering prospectusDocumentIndex
Oct 28, 2026S-3Shelf registrationDocumentIndex
Oct 20, 20268-KMaterial eventDocumentIndex
Oct 14, 20268-KMaterial eventDocumentIndex
Oct 7, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 2, 2026DEF 14AProxy / shareholder voteDocumentIndex
Sep 25, 2026EFFECTDocumentIndex
Sep 25, 2026424B3Offering prospectusDocumentIndex
Sep 22, 2026PRE 14AProxy / shareholder voteDocumentIndex
Sep 22, 20268-KMaterial eventDocumentIndex
Sep 18, 2026S-3Shelf registrationDocumentIndex
Sep 10, 2026DDocumentIndex
Sep 10, 20268-KMaterial eventDocumentIndex
Aug 28, 20268-KMaterial eventDocumentIndex
Aug 20, 20268-KMaterial eventDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Jul 16, 2026ARSAnnual report to holdersDocumentIndex
Jul 16, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 6, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
Jun 2, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 2, 2026424B3Offering prospectusDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
Apr 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 26, 202610-KAnnual reportDocumentIndex
Mar 26, 20268-KMaterial eventDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex